Safety and tolerability of GLP-1 receptor agonists: a narrative review
A 2025 narrative review in PMC specifically listed creatine monohydrate as a recommended supplement for individuals on GLP-1 receptor agonist therapy, noting its role in supporting strength and lean mass during pharmacotherapy-induced weight loss
No, valproic acid is not a controlled substance
If we only look at the protein count, we may miss some issues
JoinSkinny's own Privacy Policy names OpenLoop, OpenLoop Healthcare Partners PC, Rezilient OLH, PA, and JoinSkinny.com Healthcare Partners California, PC as affiliated medical entities
You can still increase their benefits by supplementing